Skip to main content
. 2021 May 27;28(8):2784–2788. doi: 10.1111/ene.14868

TABLE 1.

Demographics and main diagnostic features of SCA21 patients

Family A B C D
Patient I‐1 II‐2 II‐3 II‐4 II‐5
Sex M M M M M
Origin Libya Libya Italy Italy Italy
Age of onset, years 62 40 30 3 0
Age at diagnosis, years 79 46 52 12 7
Symptom of onset GA GA GA Clumsiness DD
Gait ataxia +++ + ++ ++ ++
Dysarthria ++ +
Hypokinetic signs
Hyperkinetic signs +(DY)
Ocular findings Ny Ny HS HS OP
Tremor + (postural) + (postural) + (intention) + (intention and postural)
Psychomotor delay + ++
Cognitive decline ++ + +
SARA at first visit 15 6.5 10 5 n.d.
SARA at last visit 18 6.5 23 6 n.d.
Timespan of FU 4 years 7 years 7 years 6 years
Progression rate 0.6/year 0.8/year 0.16/year
Neuroimaging CA n.d. CA CA DM
Behaviour disorder + ++
Others REM‐BD Strabismus Hearing loss
Mutation

c.509C>T

p.Pro170Leu

c.509C>T

p.Pro170Leu

c.509C>T

p.Pro170Leu

c.239C>T

p.Thr80Met

c.196G>A

p.Gly66Arg

Abbreviations: –, not present; +, mild; ++, moderate; +++, severe; CA, cerebellar atrophy; DY, dystonia; FU, follow‐up; GA, gait ataxia; HS, hypermetric saccades; ID, developmental delay; M, male; n.d., not determined; Ny, nystagmus; OP, Opsoclonus; REM‐BD, REM sleep‐behavior disorder; SARA, Scale for the Assessment and Rating of Ataxia.